Please join our staff as we participate or present in the following oral and poster presentations at the 2017 ASCO Annual Meeting
Friday, June 2
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
1:00 PM – 3:15 PM
Location: Hall D1
EXTENDED EDUCATION SESSION: Biomarkers for Immunotherapy: An Illusion or a Reality?
Vamsidhar Velcheti, MD, Chair
1:40 PM – 2:00 PM
Location: Hall D1
Biomarkers for Immune-Related Toxicities
Vamsidhar Velcheti, MD – Chair
Advertisement
Advertisement
Timing and type of side effects differ greatly from chemotherapy
Dedicated multidisciplinary teams support 84 ultra-rare cancers
Sessions explore treatment advances and multidisciplinary care
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations
Early communication between oncologists and ophthalmologist warranted
Case-based course delves into latest treatment approaches
Long-term relationship building and engagement key to gaining community trust